## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

|Membership<br>for the year may be summarised|Membership<br>for the year may be summarised|Membership<br>for the year may be summarised|as follows:|2021|2020|
|---|---|---|---|---|---|
|Full members<br>paying|full subscription|||480|483|
|Full members<br>paying|reduced|subscription||353|337|
|Associate members||||110|105|
|Parental<br>Leave||||15|16|
|Junior doctor||||147|123|
|Medical student<br>(free)||||209|163|
|||||1,314|1,227|





## 

## 

## 

## 

## 



## 

## 

## 



## 

||||||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|---|---|---|
||||||funds|funds|2021|2020|
|||||Notes|f|f|f|f|
|INCOME|||||||||
|Charitable<br>income|||||||||
|Membership<br>subscriptions||||||200,689|200,689|189,687|
|Study days||||||226,767|226,767|6,525|
|e-ELCA|||||10,000||10,000|10,000|
|Outside<br>mailings||||||11,857|11,857|9,122|
|Investment<br>income||||||131|131|592|
|TOTAL INCOME|||||10,000|439,444|449,444|215,926|
|EXPENDITURE|||||||||
|Charitable<br>activities|||||64,984|308,889|373,873|352,356|
|TOTAL EXPENDITURE|||||64,984|368,889|373,873|352,356|
|Net (expenditure)<br>/income||for the year before transfers|||(54,984)|130,555|75,571|(136,430)|
|Transfers<br>between|funds||||2,500|(2,500)|||
|NET (EXPENDITURE)/INCOME|||FOR THE YEAR||(52,484)|128,055|75,571|(136,430)|
|Fund balances at 1|December 2020||||223,295|418,774|642,069|778,499|
|FUND BALANCES|AT 30NOVEMBER 2021|||9,10|170,811|546,829|717,640|642,069|





## 

||Restricted|Unrestricted|Total|
|---|---|---|---|
||funds|funds|2020|
|Notes|f|f|f|
|INCOME||||
|Charitable<br>income||||
|Membership<br>subscriptions||189,687|189,687|
|Study days||6,525|6,525|
|e-ELCA|10,000||10,000|
|Outside<br>mailings||9,122|9,122|
|Investment<br>income||592|592|
|TOTAL INCOME|10,000|205,926|215,926|
|EXPENDITURE||||
|Charitable<br>activities|53,072|299,284|352,356|
|TOTAL EXPENDITURE|53,072|299,284|352,356|
|NET INCOME FOR THE YEAR BEFORETRANSFERS|(43,072)|(93,358)|(136,430)|
|Transfer between<br>funds|(1,200)|1,200||
|NET INCOME FOR THE YEAR|(44,272)|(92,158)|(136,430)|
|Fund balances at 1 December 2019|267,567|510,932|778,499|
|FUND BALANCES AT 30 NOVEMBER 2020|223,295|418,774|642,069|





## 




## 

||||2021|2020|
|---|---|---|---|---|
|||Notes|E|R|
|NET CASH FLOW PROVIDED BYOPERATING ACTIVITIES||1|21,762|(99,436)|
|CASH FLOWS FROM FINANCING<br>ACTIVITIES|||||
|Fixed asset additions|||||
|NET CASH FLOW|||21,762|(99,436)|
|Change<br>in cash and cash|equivalents<br>in the period||21,762|(99,436)|
|Cash and cash equivalent|at start ofthe period||639,462|738,898|
|Cash and cash equivalents|at the end ofthe period||661,224|639,462|



## 

||||||2021|2020|
|---|---|---|---|---|---|---|
||||||k|6|
||Net movement||in funds for the period||75,571|(136,430)|
||Depreciation|||||1,024|
||Increase|in debtors|||21,432|(38,027)|
||Increase|in creditors|||(75,242)|73,997|
||Net cash|flow|from operating|activities|21,762|(99,436)|
|2|ANALYSIS OF CASH AND|||CASH EQUIVALENTS|||
||||||2021|2020|
||||||k|'Z|
||Cash at|bank|and in hand||661,224|639,462|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|||||||||Surplus I|
|---|---|---|---|---|---|---|---|---|
|STUDY DAYS AND EVENTS||||||Income|Expenditure|(deficit)|
|||||||K|K|K|
|Ethics Committee<br>January 2021||||||5,168|(1,000)|4,168|
|Ethics Committee<br>October 2021||||||4,740|(1,500)|3,240|
|Go With Your Gut November||||||6,479|(2,000)|4,479|
|Neuro SIF||||||2,600|(1,000)|1,600|
|Postgrad SIF||||||2,840|(500)|2,340|
|Hospice & Community|Doctors|||Medical Updates||8,116|(2,000)|6,116|
|Pain Management||||||5,560|(2,000)|3,560|
|Trainees Committee||||||3,015|(1,000)|2,015|
|PCC 2021||||||188,249|(115,220)|73,029|
|||||||226,767|(126,220)|100,547|
||||||Restricted|Unrestricted|Total|Total|
|CHARITABLE ACTIVITIES EXPENDITURE|||||funds|funds|2021|2020|
||||||K|K|K|K|
|Direct Charitable<br>Expenditure|||||||||
|Study days (see note 3)||||||126,220|126,220|95,180|
|e-ELCA|||||64,984||64,984|53,072|
|British Medical Journal|Subscriptions|||||19,880|19,880|25,166|
|Sage Publications<br>(Palliative|||Medicine Journal)|||12,200|12,200|12,000|
|Pharmaceutical<br>Press||||||53,086|53,086|34,434|
|Advertising||||||536|536|4,214|
|Support Costs|||||||||
|Committee<br>meetings||||||||5,636|
|Contribution<br>for President||and||Vice|||||
|President's<br>costs (see note 5)||||||18,278|18,278|24,782|
|Secretariat and Conference||||||62,349|62,349|80,852|
|Travel and accommodation||||||||1,213|
|Office expenditure<br>and|IT|support||||7,980|7,980|9,446|
|Stationery,<br>photocopying||and|printing|||980|980|1,568|
|Postage||||||1,476|1,476|295|
|Telephone||||||||496|
|Insurance||||||825|825|554|
|Bank charges||||||30|30|30|
|Legal and professional|fees|||||2,114|2,114|107|
|Depreciation||||||||1,024|
|Accountancy<br>and independent||||examination||2,935|2,935|2,287|
||||||64,984|308,889|373,873|352,356|





## 

## 

## 

|TANGIBLE FIXEDAS|SET|S|||
|---|---|---|---|---|
||||Website|Total|
||||f|6|
|COST|||||
|At beginning<br>and end ofyear|||3,072|3,072|
|DEPRECIATION|||||
|At beginning<br>ofyear|||3,072|3,072|
|Charge for the year|||||
|At end ofyear|||3,072|3,072|
|NET BOOK VALUE|||||
|At end ofyear|||||
|At beginning<br>ofyear|||||
|DEBTORS|||2021|2020|
|Other trade debtors|||13,202|12,057|
|Prepayments<br>(including|PCC)||81,596|104,173|
||||94,798|116,230|
|CREDITORS: amounts|falling due within one year||2021|2020|
||||6|6|
|Secretariat costs|||6,015|7,943|
|Other accruals|||5,194|5,192|
|Deferred income (including||PCC)|18,561|90,055|
|Other creditors|||8,612|10,433|
||||38,382|113,623|





## 

## 

|RESTRICTED|FUNDS||Balance at||||Balance at 30|
|---|---|---|---|---|---|---|---|
|||1|December 2020|Income|Expenditure|Transfers|November<br>2021|
||||E|E|E||E|
|BRCT|||13,935||||13,935|
|e-ELCA|||209,360|10,000|(64,984)|2,500|156,876|
||||223,295|10,000|(64,984)|2,500|170,811|
||||Balance at||||Balance at 30|
|||1|December 2019|Income|Expenditure|Transfers|November<br>2020|
|BRCT|||13,935||||13,935|
|e-ELCA|||253,632|10,000|(53,072)|(1,200)|209,360|
||||267,567|10,000|(53,072)|(1,200)|223,295|



## 

## 

|UNRESTRICTED|UNRESTRICTED|FUNDS|Balance at||||Balance at 30|
|---|---|---|---|---|---|---|---|
||||1 December 2020|Income|Expenditure|Transfers|November<br>2021|
||||E|E|E||E|
|Education|fund||100,929|226,767|(126,220)||201,476|
|Other unrestricted||funds|317,845|212,677|(182,669)|(2,500)|345,353|
||||418,774|439,444|(308,889)|(2,500)|546,829|
||||Balance at||||Balance at 30|
||||1 December 2019|Income|Expenditure|Transfers|November<br>2020|
||||E|E|E||E|
|Education|fund||189,584|6,525|(95,180)||100,929|
|Other unrestricted||funds|321,348|199,401|(204,104)|1,200|317,845|
||||510,932|205,926|(299,284)|1,200|418,774|



## 



## 

|11|ANALYSIS OF NET ASSETS BETWEEN FUNDS|ANALYSIS OF NET ASSETS BETWEEN FUNDS|Restricted|Unrestricted|TOTAL|
|---|---|---|---|---|---|
||||funds|funds|2021|
||Forthe|year ended 30November 2021||6|R|
||Fixed assets|||||
||Current|assets|170,811|585,211|756,022|
||Current|liabilities||(38,382)|(38,382)|
||||170,811|546,829|717,640|
||||Restricted|Unrestricted|TOTAL|
||||funds|funds|2020|
||Forthe|year ended 30November 2020|6|E|f|
||Fixed assets|||||
||Current|assets|223,295|532,397|755,692|
||Current|liabilities||(113,623)|(113,623)|
||||223,295|418,774|642,069|



